Fulgent Therapeutics
UEI: JVZDRESJLD82
• CAGE: 7BRL2
Overview
Parent Awardee
Company Description
Fulgent is an accredited leader in clinical diagnostic genetic sequencing.
Name
Fulgent Therapeutics
Website
Headquarters
El Monte, CA
United States
United States
Most Recent Award
Oct. 1, 2024
Calculating
Federal contract recipient
FULGENT THERAPEUTICS LLC
(UEI JVZDRESJLD82, CAGE 7BRL2)
is headquartered in El Monte CA.
Its primary registered NAICS is 621511 Medical Laboratories.
The partnership
was founded in September 2011 and
federally registered in
March 2015.
Federal Award Analysis
Fulgent Therapeutics federal award history
$-
Contracts
$-
Subcontracts
$-
Grants
$-
Subgrants
$-
Total
No Results
Calculating
Calculating
No Results
Calculating
Calculating
No Results
Calculating
Calculating
| Year | Contracts | Subcontracts | Grants | Subgrants |
|---|
No Results
Calculating
Calculating
No Results
Calculating
Calculating
Federal Registration and Certifications
Legal Name
FULGENT THERAPEUTICS LLC
UEI
JVZDRESJLD82
CAGE Code
7BRL2
Primary NAICS
SBA Certifications
None
Self Certifications
None
Entity Structure
Partnership or Limited Liability Partnership
Purpose of Registration
Federal Contracts and Assistance
Date Founded
Sept. 19, 2011
Initial Registration
March 2, 2015
Last Registration
Dec. 2, 2024
Registration Activation
Sept. 4, 2024
Registration Expiration
Sept. 3, 2025
Fiscal Year End
December 31
Reported Entity Types
For Profit Organization
Limited Liability Company
Limited Liability Company
State of Incorporation
CA
Country of Incorporation
USA
Employees
1001-1500
Reported NAICS
Reported PSC
Accepts Credit Cards
Yes
People
Vendor contacts at Fulgent Therapeutics
GSA Schedules and Price Lists
- Fulgent Therapeutics
- PoP: 4/14/18 - 1/31/24 (Ended)
- Type: Medical Laboratory Testing and Analysis Services (FSS 621 II)
- Obligated: $77,826
- View | Download